Mycobacteriosis and HIV infection: The new public health challenge

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue SUPPL. B, 1996, Pages 113-120

  Porter, John D H ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD4 ANTIGEN; TUBERCULOSTATIC AGENT;

AFRICA SOUTH OF THE SAHARA; BCG VACCINATION; CASE FINDING; CHEMOPROPHYLAXIS; CONFERENCE PAPER; EMERGENCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM TUBERCULOSIS; PATIENT COMPLIANCE; POVERTY; PUBLIC HEALTH; SOCIAL STATUS; SPUTUM SMEAR; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

EID: 0029813778     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.suppl_b.113     Document Type: Conference Paper

References (33)

1. American Thoracic Society. (1992). Control of tuberculosis in the United States. American Review of Respiratory Disease 146, 1623-33.
2. Barnes, P. F., Bloch, A. B., Davidson, P. T. & Snider, D. E. (1991). Tuberculosis in patients with human immunodeficiency virus infection. New England Journal of Medicine 324, 1645-50.
3. Chaisson, R. E. & Hopewell, P. C. (1989). Mycobacteria and AIDS mortality. American Review of Respiratory Disease 139, 1-3.
4. Centers for Disease Control. (1992). Transmission of multidrug resistant tuberculosis among immunocompromised persons in a correctional system - New York 1991. Morbidity and Mortality Weekly Report 41, 507-9.
5. De Cock, K. M. (1994). The interaction of tuberculosis and HIV infection. In Tuberculosis - Back to the Future (Porter, J. D. H. & McAdam, K. P. W. J., Eds), pp. 35-54. Wiley, London.
6. De Cock, K. M., Grant, A. & Porter, J. D. H. (1995). Preventive therapy for tuberculosis in HIV-infected persons: international recommendations, research and practice. Lancet 345, 833-6.
7. De Cock, K. M., Soro, B., Coulibaly, I. M. & Lucas, S. B. (1992). Tuberculosis and HIV infection in Sub-Saharan Africa. Journal of the American Medical Association 368, 1581-7.
8. Elliott, A. M., Lui, N., Tembo, G., Halwiindi, B., Steenbergen, G., Machiels, L. et al. (1990). Impact of HIV on tuberculosis in Zambia: a cross sectional study. British Medical Journal 301, 412-5.
9. Elliott, A. M., Hayes, R. J., Halwiindi, B., Luo, N., Tembo, G., Pobee, J. D., et al. (1993). The impact of HIV on infectiousness of pulmonary tuberculosis: a community study. AIDS 7, 981-7.
10. Enarson, D. A. (1995). The International Union Against Tuberculosis and Lung Disease Model National Tuberculosis Programmes. Tubercule and Lung Disease 76, 95-7.
11. Frieden, T. R., Sterling, T., Pablo-Mendez, A., Kilburn, J. O., Cauthen, G. M. & Dooley, S. W. (1993). The emergence of drug resistant tuberculosis in New York City. New England Journal of Medicine 328, 521-6.
12. Harries, A. D., (1994). The association between HIV and tuberculosis in the developing world. In Clinical Tuberculosis (Davies, P. D. O., Eds), pp. 241-64. Chapman and Hall, London.
13. Hopewell, P. C. (1994). The cure: organisation and administration of therapy for tuberculosis. In Tuberculosis - Back to the Future (Porter, J. D. H. & McAdam, K. P. W. J., Eds), pp. 99-120. Wiley, London.
14. Horsburgh, C. R. (1991). Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. New England Journal of Medicine 324, 1332-8.
15. Horsburgh, C. R., Mason, U. G., Farhi, D. C. & Iseman, M. D. (1985). Disseminated infection with Mycobacterium avium-intracellulare: a report of 13 cases and a review of the literature. Medicine 64, 36-48.
16. Hoy, J., Much, A., Sandland, M., Grayson, L., Lucas, R. & Dwyer, B. (1990). Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteraemia in AIDS patients. Journal of Infectious Diseases 161, 801-5.
17. McKeown, T. (1979). The Role of Medicine. Blackwell Scientific Publications, Oxford.
18. Metroka, C. (1990). Prophylaxis for Pneumocystis carinii pneumonia and other opportunistic infections. AIDS Targeted In Newsletter 4, 1-2.
19. Murray, C. J. L., Styblo, K. & Rouillon, A. (1990). Tuberculosis in developing countries: burden, intervention and cost. Bulletin International Union Against Tuberculosis and Lung Disease 65, 2-20.
20. Nisar, M., Narula, M., Beeching, N. & Davies, P. D. O. (1992). HIV related tuberculosis in England and Wales. Tubercle Lung Disease 73, 200-2.
21. Nunn, P. (1994). Impact of interaction with HIV - discussion. In Tuberculosis - Back to the Future (Porter, J. D. H. & McAdam, K. P. W. J., Eds), pp. 49-52. Wiley, London.
22. Nunn, P., Brindle, R., Carpenter, L., Odhiambo, J., Wasunna, K., Newman, R. et al. (1992). Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya: analysis of early (6 month) mortality. American Review of Respiratory Disease 146, 849-54.
23. Nunn, P. P., & Felten, M. (1994). Surveillance of resistance to antituberculosis drugs in developing countries. Tubercule Lung Disease 75, 163-7.
24. Nunn, P., Porter, J. & Winstanley, P. (1993). Thiacetazone - avoid like poison or use with care? Transactions of the Royal Society of Tropical Medicine and Hygiene 87, 578-82.
25. Pape, J., Jean, S. S., Ho, J. L., Hafner, A. & Johnson, W. A. (1993). Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 342, 268-72.
26. Ponnighaus, J. M., Mwanjasi, L. J., Fine, P. E. M., Shaw, M., Turner, A. C., Oxborrow, S. M. et al. (1991). Is HIV infection a risk factor for leprosy? International Journal of Leprosy 59, 221-8.
27. Raviglione, M. C., Snider, D. E. J. & Kochi, A. (1995). Global epidemic of tuberculosis. Morbidity and Mortality of a worldwide epidemic. Journal of the American Medical Association 273, 220-6.
28. Raviglione, M. C., Sudre, P., Rieder, H. L., Spinaci, S. & Kochi, A. (1993). Secular trends of tuberculosis in western Europe. Bulletin of the World Health Organization 71, 291-306.
29. Rieder, H. L. (1994). Tuberculosis and human immunodeficiency virus infection in industrialised countries. In Clinical Tuberculosis (Davies, P. D. O., Ed.), pp. 227-40. Chapman & Hall, London.
30. Selwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E. & Vermund, S. H. (1989). A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. New England Journal of Medicine 320, 545-50.
31. Selwyn, P. A., Sckell, B. M., Alcabes, P., Friedland, G. H., Klein, R. S. & Shoenbaum, E. E. (1992). High risk of active tuberculosis in HIV infected drug users with cutaneous anergy. Journal of the American Medical Association 268, 504-9.
32. World Health Organisation. (1992). Managing Tuberculosis at the District Level. WHO, Geneva.
33. World Health Organisation. (1994). The Global Tuberculosis Situation 1994. WHO, Geneva.